非洲婴幼儿恶性疟疾65例临床分析

目的探讨非洲婴幼儿恶性疟疾临床特点、诊治方法及其转归。方法回顾性分析确诊为恶性疟疾65例（其中脑型疟19例）住院婴幼儿的临床资料。结果65例恶性疟疾婴幼儿的血涂片均见到恶性疟原虫；临床表现以发热（100％），呕吐32例（49．2％），腹泻23例（36．9％），咳嗽27例（41．5％），抽搐12例（18．5％），意识障碍19例（29．1％），贫血52例（80．0％），脾肿大46例（71．6％），肝肿大41例（63．1％），脑膜刺激征19例（29．1％）。65例均接受青蒿琥酯抗疟的综合治疗，治愈60例，死亡5例。结论婴幼儿恶性疟疾临床表现复杂多样化且不够典型，尽早诊断、及时治疗是改善本病预后的关键；青蒿琥酯是治疗疟疾安全、有效的首选药物。     

西双版纳州景洪市各类发热病人疟原虫检出情况

目的了解景洪市不同人群疟原虫感染情况，为制定疟疾防治措施提供依据。方法由景洪市疾病预防控制中心、州（市）各医院、农场医院、乡镇卫生院、村卫生室对各类发热病人进行涂片镜检或送检疟原虫。结果2002年1—12月全市血检各类发热病人11841人，疟原虫阳性947例，平均疟原虫检出率为7．99％，间日疟占72．02％、恶性疟占27．98％。其中各类流动人群的疟原虫平均检出率为10．41％（402／3682），明显高于当地居民的6．83％（545／7979）（x^2=44．81，P〈0．01）。结论各类流动人群发热病人的疟原虫检出率高，做好流动人口，特别是出、入境边民的管理是控制目前景洪市疟疾旒行的一项重要措施。     

Quinimax治疗非洲恶性疟疾的临床疗效研究

目的观察Quinimax对非洲恶性疟疾的临床疗效。方法用法国生产Quinimax静脉注射治疗非洲恶性疟疾213例。同时用国产蒿甲醚胶囊口服治疗恶性疟疾213例进行疗效比较，5d 1疗程。结果Quinimax组治疗有效率100％，其中临床治愈率56．3％，显效率43．7％，血内疟原虫清除率56．3％。复燃4．2％；蒿甲醚胶囊组治疗有效率100％，其中临床治愈率71．4％，显效率28．6％，血内疟原虫清除率71．4％。复燃5．6％。两组临床治愈率比较差异具显著性（P〈0．01）；血内疟原虫清除率比较差异具显著性（P〈0．01）。Quinimax组对疟原虫血内清除率低于蒿甲醚胶囊组差异具显著性（P〈0．01）。结论Quinimax和蒿甲醚胶囊对非洲黑人恶性疟疾的治疗均具有相当高的临床疗效，但5d疗法Quinimax对疟原虫血内清除率较低，该地区恶性疟疾对Quinimax可能产生了抗药性。     

疟疾12例临床及血液学特征

目的探讨疟疾患者临床特征、外周血象及骨髓象的变化。方法回顾性分析12例经骨髓涂片找到疟原虫证实为疟疾患者的临床资料。结果12例疟疾患者周期性发热12例,肝脾肿大6例,均无淋巴结肿大。外周血象:三系减少8例、二系减少4例。血涂片中易见单核细胞及异型淋巴细胞,均未见疟原虫。骨髓象:骨髓增生活跃6例,骨髓增生明显活跃6例,粒红比例<2∶1为8例,产生血小板型巨核细胞≤3/片11例。12例患者的骨髓涂片中均找到间日疟原虫。结论当外周血涂片检查疟原虫阴性时,了解疟疾的临床及血液学特征有助于疟疾患者的早期诊治。     

重症急性胰腺炎死亡危险因素分析

目的探讨重症急性胰腺炎（Severe acute pancreatitis，SAP）病人死亡的危险因素。方法回顾性分析68例SAP病例资料，将危险因素与病人死亡之间的关系进行统计学分析。结果68例中存活55例，死亡13例，病死率19．1％。非手术治疗61例，治愈53例（53／61），治愈率86．9％，死亡8例（8／61），病死率13．1％；外科手术治疗7例，治愈2例（2／7），治愈率28．6％，死亡5例（5／7），病死率71．4％。死亡13例中多脏器功能衰竭（MOSF）7例（7／13），占53．8％，呼吸衰竭3例（3／13），占23．1％，肠功能衰竭2例（2／13），占15．4％，急性肾功能衰竭1例（1／13），占7．7％；存活55例中MOSF7例（7／55），占12．7％，呼吸衰竭6例（6／55），占10．9％，急性肾功能衰竭6例（6／55），占10．9％，肠功能衰竭1例（1／55），占1．8％。手术组与非手术组死亡率比较差异有显著性，死亡组中MOSF与单脏器功能衰竭死亡率比较差异均有显著性。结论MOSF、呼吸衰竭、肠功能衰竭、低蛋白血症、手术干预是病人死亡的危险因素；MOSF是病人死亡的主要原因。     

云南小磨高速公路沿线施工前疟疾流行现状调查

目的 了解小磨高速公路沿线疟疾流行现状，为制定防护措施提供依据。方法进行沿线居民带虫调查、疟史访问、施工人员带虫调查、两个乡卫生院近2年发热病人疟原虫检出情况及媒介按蚊调查。结果2003～2004年居民及小学生疟史率在12.4％～15.4％之间，平均13．9％；带虫率分别为0.58％（2／345）、0.33％（1／306）。勐仑、磨憨两个卫生院2003、2004年发热病人血检，阳性率分别为5．6％（89／1597）、11.6％（24／207），平均8.3％，其中勐仑乡卫生院来自于内地的流动人口感染疟疾平均65.8％。结论小磨路沿线目前疟疾流行严峻，急待加强施工人群的疟疾防治工作。     

海南省白沙县1986─1995年血栓疟原虫结果分析

目的：全面了解白沙县的疟疾传染源，给当前控制疟疾提供科学依据。方法：采用建立健全基层卫生组织和卫生院镜检站，全面开展发热病人、疟疾疫点（居民点）调查、流动人口的血栓，以查明疟疾传染源。结果；在10年的血检中，发热病人血检发现疟原虫阳性6217例，阳性事3．26％（0.79－5．85％）；居民带虫者892例，带虫率1.37％（0.17－3．01％）；流动人口疟原虫阳性4285例，阳性车6.71％（2．23－11.64％）。结论：血检疟原虫阳性数比疫情报告数多2021例．说明血栓疟原虫工作给疟防工作提供科学依据，是当前控制疟疾中不可缺少的手段，应发展和提高。     

大面积脑梗死55例的临床特点分析

目的：探讨大面积脑梗死的诊断、治疗及临床特点。方法：回顾分析55例大面积脑梗死的临床资料。结果：55例大面积脑梗死动态起病24例（43．6％），意识障碍39例 （70．9％），失语12例（21．8％），偏瘫55例（100％），死亡15例（27．3％）。结论：大面积脑梗死病死率高、致残率高、预后差，严重影响患者生活质量，溶栓、抗凝、降纤、活血化瘀治疗均未取得明显优势。     

液基细胞学配合阴道镜检查在诊断宫颈病变中的临床应用及意义

目的：探讨液基细胞学（TCT）配合阴道镜检查对宫颈病变的诊断价值。方法：对3010例来我院就诊的妇科患者行液基细胞学检查，对阳性涂片360例及可疑病例33例行阴道镜下活组织检查。结果：3010例涂片中阳性360例（11．96％）。其中ASC 253例（8．4％）；LSIL 74例（2．46％）；HSIL 27例（0．9％）；SCC6例（0．2％）。细胞学检查与阴道镜下活检病理结果的符合率分别为LSIL64．35％（74／115）、HSIL93．19％（27／29）、SCC100％（6／6）。结论：采用TCT联合阴道镜下活检能提高宫颈病变的阳性的诊断率。     

4例输入性重症疟疾合并COVID-19诊疗分析

对4例重症疟疾合并COVID-19确诊患者的流行病学特征、临床表现、实验室检查、治疗经过及其预后进行回顾性分析，探讨输入性重症疟疾合并新型冠状病毒肺炎（corona virus disease 2019,COVID-19）病例的临床特征及治疗效果，为重症疟疾合并COVID-19防控提供科学依据。4例重症疟疾患者均为同批非洲返国人员，男性，年龄40～54岁，均有非洲工作和生活史；4例均，急性起病，发热、腹泻和乏力纳差，3例畏寒、寒战和恶心呕吐，2例头痛头晕、意识不清、肌肉酸痛和咳嗽2例，1例咳痰、咽痛流涕和小便失禁。4例均行咽拭子新型冠状病毒（2019-nCOV）核酸检测阳性确诊，外周血涂片镜检均找到恶性疟原虫且符合高疟原虫血症，同时均伴有肝功能异常及严重低蛋白血症，肾损害3例，血脂异常3例，高胆红素血症2例，3例降钙素原不同程度升高，乳酸酸中毒2例，低血糖1例；胸部CT提示病毒性肺炎改变1例。4例根据病情不同予个体化治疗方案，均好转出院，复查2019-nCOV核酸及血涂片镜检疟原虫阴性。输入性疟原虫与新型冠状病毒（severe acuterespiratory syndrome cor...     

Value of D-Dimers in patients with acute aortic dissection

Objective: To evaluatel the value of D-dimers in patients with acute aortic dissection (AAD). Methods: This study consisted of 16 patients with AAD and 27 non-AAD patients. Serum D-dimets were measured by Sta-Liatest D-DI immunoturbidimetric assay. Results: D-dimer level was higher (P ＜ 0.001) in patients with AAD(7.91 ± 5.52 μg/ml) than that in non- AAD group(1.57±1.24 μg/ml). D-dimer was positive (＞0.4 μg/ml) in all patients with AAD and in 10 control group patients (37%). Among patients with acute AAD, D-dimers tended to be higher in Stanford A than in Stanford B (8.67 ± 4.31 μg/ml vs. 3.24±1.27 μg/ml, P ＜0.01). D-dimer values tended to be higher in more extended disease(3.84 ± 1.65 μg/ml, 8.57 ± 3.58 μg/ml and 11.87 ± 5.69 μg/ml in thoracic aorta, thoracic and abdominal aorta, thoracic and abdominal aorta and iliacal arteries, respectively, P ＜ 0.05 for both 8.57 ± 3.58 and 11.87 ± 5.69 vs. 3.84 ± 1.65 ). Including the control group into the analysis, we found a sensitivity of 100%, a negative predictive value of 100%, and a specificity of 66% and a positive predictive value of 64% for D-dimer in diagnosis of AAD in our patients with suspected AAD. Conclusion: D-dimer was elevated in patients with AAD. A negative D-dimer test result could be useful in excluding AAD.     

Research of combined liver-kidney transplantation model in rats

Objective： To set up a simple and reliable rat model of combined liver-kidney transplantation. Methods： SD rats served as both donors and recipients. 4℃ sodium lactate Ringer＇s was infused from portal veins to donated livers,and from abdominal aorta to donated kidneys, respectively. Anastomosis of the portal vein and the inferior vena cava （IVC） inferior to the right kidney between the graft and the recipient was performed by a double cuff method, then the superior hepatic vena cava with suture. A patch of donated renal artery was anastomosed to the recipient abdominal aorta. The urethra and bile duct were reconstructed with a simple inside bracket. Results： Among 65 cases of combined liver-kidney transplantation, the success rate in the late 40 cases was 77.5%. The function of the grafted liver and kidney remained normal. Conclusion： This rat model of combined liver-kidney transplantation can be established in common laboratory conditions with high success rate and meet the needs of renal transplantation experiment.     

APPLICATION OF LORNOXICAM TO PATIENT-CONTROLLED ANALGESIA IN PATIENTS UNDERGOING ABDOMINAL SURGERIES

FOR anesthesiologis s ,treatingpostoperativepainhas alwaysbeen a problem.Althoughopioidshave been provedtobe effective,theirsideeffectscouldnotbeignored.With thedevelopmentofscienceand pharmacology,many drugs with aspectsof satisfactoryanalgesicefficacyand couldbe welltoleratedby patientshave been developed.And lornoxicamisone of them, which isa non-steroidalanti-inflammatorydrug (NSAID ), with analgesic, anti-infl-ammatory,andantipyreticproperties.Itseliminationhalf-time(3 to 5 hours) isle…     

BLOOD PRESSURE CHANGE WITH AGE IN SALT-SENSITIVE TEENAGERS

Objective To observe blood pressure change with age in salt-sensitive teenagers whose salt sensitivity were determined by repeated testing.Methods Salt sensitivity was determined through intravenous infusion of normal saline combined with volume-depletion by oral diuretic furosemide in 55 teenagers. After five years, salt sensitivity was re-examined and subject blood pressure was followed up. Blood pressure changes in salt-sensitive teenagers were compared to that of non-salt sensitive teenagers over five years.Results After 5 years, the repetition rate of salt sensitivity determined by intravenous saline loading is 92.7%. In teenagers with salt sensitivity on the baseline, both the systolic blood pressure increments and increment rates were much higher than non-salt sensitive teenagers (12.7±12.1 mmHg vs. 2.8±5.2 mmHg, P＜ 0.01; 12.2%± 12.0% vs. 2.5% ±4.4%, P＜ 0.001,respectively). There was a similar trend for diastolic blood pressure (8.4 ± 6.4 mmHg vs. 3.7 ± 6.4 mmHg, P = 0.052; 13.2% ±10.6 % vs. 6.8%± 10.1%, P = 0.053, respectively).Conclusions Salt sensitivity determined by intravenous saline loading showed good reproducibility. Blood pressure increments with age were much higher in salt-sensitive teenagers than non-salt sensitive teenagers, especially in terms of systolic blood pressure.     

Acupuncture Combined with Spinal Tui Na for Treatment of Primary Dysmenorrhea in 30 Cases

Objective: To observe the therapeutic effects in acupunture treatment of primary dysmenorrhea combined with spinal Tui Na, and study its mechanism. Methods: Thirty cases of the treatment group were treated by acupuncture combined with spinal Tui Na, and thirty cases in the control group were treated by routine acupuncture. Results: The total effective rate was 93.3% in the treatment group, and 73.3% in the control group, with a significant difference between the two groups (P<0.05). Conclusions: Acupuncture combined with spinal Tui Na has good prospects for treatment of primary dysmenorrhea.     

Luo Lingjie's Experience in Treating Chronic Nephropathy

In treating chronic nephropathy,Luo Lingjie,a chief physician,pays attention to regulating the balance between yin and yang,treating infection if present,and removing pathogenic factors.He prescribes gentle drugs and uses carefully strongly warming-tonifying ones,emphasizes the importance of persuading the patient to persist in treatment with medication and nurse one's health for recuperation,and is good at combined use of TCM and western medicine therapy and brings the merits of various therapies into full play,with obvious theraoeutic effects.     

Dr.Zhang Ren's Experience in the Acupuncture Treatment of Different Diseases with the Same Therapeutic Principle

Dr.Zhang Ren,the chief physician,is the chairman of Shanghai Acupuncture and Moxibustion Association.Having been engaged in medicine for about 40 years,he is experienced in treating various intractable diseases.In his long years of clinical practice,he advocates taking the TCM differentiation as the basis to seek for the acupuncture method for treatment of modern intractable diseases.The author of this essay had the fortune to follow Dr.Zhang in study.The following is a summary of Dr.Zhang's experience in the acupuncture treatment for different intractable diseases with the same therapeutic principle.     

安心颗粒对急诊经皮冠状动脉介入术后生活质量影响的研究

目的：评价使用安心颗粒对急诊经皮冠状动脉介入术（PPCI）术后生活质量的影响.方法：将160例接受PPCI的急性ST段抬高型心肌梗死患者随机分为安心颗粒组（术前顿服安心颗粒8.8g,术后安心颗粒4.4 g/次,每日2次）和对照组（仅接受基础药物治疗）.所有患者均服用阿司匹林、氯吡格雷和阿托伐他汀.分别在入院时、出院前1d、出院后180 d时,应用心肌梗死多维度量表（MIDAS）、中文版SF-36评价量表对患者生活质量评分.并观察术后30 d以内的出血并发症、血小板减少症发生情况.结果：入院时和出院前1d,两组患者的心肌梗死MIDAS、SF-36量表评分比较无差异（P＞0.05）;出院后180 d时,与对照组比较,安心颗粒组MIDAS、SF-36评分明显减低（P＜0.05）;组内与入院时比较,两组出院前1d、出院后180 d时,MIDAS、SF-36评分均降低（P＜0.05）.两组患者在随访期间均无大量出血、少量出血、重度和极重度血小板减少症发生,安心颗粒组有4例、对照组有7例发生不明显出血（P＞0.05）.两组发生轻度血小板减少症的患者数比较无差异（P＞0.05）.结论：PPCI使用安心颗粒,能改善急性ST段抬高型心肌梗死患者的生活质量,且不增加出血风险.     

The comparative studies of the influences of Urapidil and Nicardipine on sino-atrial node function, atrio-ventricular node function and hemodynamics

Objective:To investigate the influences of urapidil and nicardipine on rabbit sinus function,atrio-ventricular node function and hemodynamics.Methods:Thirty-two Angora's rabbits were selected and randomly divided into four groups.U1 group:urapidil 0.25 mg/kg;U2 group:urapidil 0.5 mg/kg;N1 group:nicardipine 10 μg/kg;N2 group:nicardipine 20 μg/kg.All these medicine were administrated within 30 seconds.Measurements were taken before and after the administration of urapidil or nicardipine for the following data:mean blood pressure(MAP),heart rate(HR),sino-atrial conduction time(SACT),maximal sinoatrial recovery time(SNRTmax)corrected sinus node recovery time(CSNRT),index of sinus node recovery time(SNRTI),Wenckebach A-V conduction frequency (WB),and P-R interval.Results:Significant MAP and HR changes were identified in all of the four groups before and after administration of both urapidil and nicardipine.No significant changes could be found in the rest of the parameters.Intergroup analysis showed that SACT and CSNRT of N1 and N2 groups were shorter than those of the U2 group(P＜0.01);the MAP decreased(P＜0.01)and the HR increased drastically(P＜0.01).Conclusions:Neither urapidil(0.25 mg/kg,0.5 mg/kg)nor nicardipine(10μg/kg,20μg/kg)has any significant influence on rabbit sinus function or rabbit atrio-ventricular node function.Nicardipine could be a better choice than urapidil for parafunctional sinus node patients.